How biomarkers are changing cancer care
Wednesday, February 2, at 1:00 p.m. ET / 10:00 a.m. PT
Biomarkers, including genetic alterations in tumor cells and even pieces of DNA that can be detected in the blood, are changing the way that doctors treat cancer. A look at some of the latest technological advances.
- Anna D. Barker, Ph.D., chief strategy officer, Ellison Institute for Transformative Medicine of USC; distinguished visiting fellow, complex systems, Arizona State University
- George Demetri, M.D., director, Sarcoma Center at Dana-Farber Cancer Center; director, Ludwig Center at Harvard
- Suzanne Topalian, professor of surgery and oncology, Johns Hopkins University School of Medicine; associate director, Bloomberg-Kimmel Institute for Cancer Immunotherapy
- Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)
- Josina Reddy, M.D., Ph.D., vice president of product development for lung, agnostic, skin, rare cancers, Genentech (sponsor speaker)
The decisions around editorial speakers, programming and subsequent conversation(s) are driven by STAT’s editorial staff. The sponsor has no input or control over editorial conversation that occurs during the event and the speakers have received no financial compensation.